Eledon Pharmaceuticals Valuation
| ELDN Stock | USD 1.57 0.03 1.88% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Eledon Pharmaceuticals shows a prevailing Real Value of $5.24 per share. The current price of the firm is $1.57. Our model computes the value of Eledon Pharmaceuticals from reviewing the firm fundamentals such as Current Valuation of (11.02 M), shares owned by institutions of 38.76 %, and Shares Owned By Insiders of 5.42 % as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting Eledon Pharmaceuticals' valuation include:
Price Book 0.5027 | Enterprise Value -11 M | Enterprise Value Ebitda 0.2061 | Forward PE 2.1896 |
Undervalued
Today
Please note that Eledon Pharmaceuticals' price fluctuation is moderately volatile at this time. Calculation of the real value of Eledon Pharmaceuticals is based on 3 months time horizon. Increasing Eledon Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Eledon Pharmaceuticals is useful when determining the fair value of the Eledon stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Eledon Pharmaceuticals. Since Eledon Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Eledon Stock. However, Eledon Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.57 | Real 5.24 | Target 16.5 | Hype 1.57 | Naive 1.35 |
The real value of Eledon Stock, also known as its intrinsic value, is the underlying worth of Eledon Pharmaceuticals Company, which is reflected in its stock price. It is based on Eledon Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Eledon Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Eledon Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Eledon Pharmaceuticals helps investors to forecast how Eledon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Eledon Pharmaceuticals more accurately as focusing exclusively on Eledon Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Eledon Pharmaceuticals' intrinsic value based on its ongoing forecasts of Eledon Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Eledon Pharmaceuticals' closest peers. When choosing an evaluation method for Eledon Pharmaceuticals, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Eledon Pharmaceuticals Investments |
|
Eledon Valuation Trend
Knowing Eledon Pharmaceuticals' actual value is paramount for traders to make sound investment determinations. Eledon Pharmaceuticals' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Eledon Pharmaceuticals' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Eledon Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Eledon Market Cap
Eledon Pharmaceuticals is one of the top stocks in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 44.89 Billion. Eledon Pharmaceuticals adds roughly 39.7 Million in market capitalization claiming only tiny portion of equities under Health Care industry.Eledon Pharmaceuticals Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Eledon Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Eledon Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eledon Pharmaceuticals competition to find correlations between indicators driving Eledon Pharmaceuticals's intrinsic value. More Info.Eledon Pharmaceuticals is one of the top stocks in price to book category among related companies. It is one of the top stocks in beta category among related companies totaling about 1.85 of Beta per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value Eledon Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Eledon Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eledon Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Eledon Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Eledon Pharmaceuticals and how it compares across the competition.
About Eledon Pharmaceuticals Valuation
The stock valuation mechanism determines the current worth of Eledon Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Eledon Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Eledon Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Eledon Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Eledon Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eledon Pharmaceuticals. We calculate exposure to Eledon Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Eledon Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -374 K | -355.3 K | |
| Pretax Profit Margin | (174.11) | (182.82) | |
| Operating Profit Margin | (138.49) | (145.41) | |
| Net Loss | (171.08) | (179.64) | |
| Gross Profit Margin | (0.47) | (0.50) |
8 Steps to conduct Eledon Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Eledon Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Eledon Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Eledon Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Eledon Pharmaceuticals' revenue streams: Identify Eledon Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Eledon Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Eledon Pharmaceuticals' growth potential: Evaluate Eledon Pharmaceuticals' management, business model, and growth potential.
- Determine Eledon Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Eledon Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Eledon Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Eledon Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 24.6 M | |
| Forward Price Earnings | 2.1896 |
Eledon Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Eledon Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Eledon we look at many different elements of the entity such as Eledon's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Eledon Pharmaceuticals' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Eledon Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Eledon Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Eledon Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Eledon Pharmaceuticals' worth.When determining whether Eledon Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eledon Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eledon Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eledon Pharmaceuticals Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eledon Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.Note that the Eledon Pharmaceuticals information on this page should be used as a complementary analysis to other Eledon Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Eledon Stock analysis
When running Eledon Pharmaceuticals' price analysis, check to measure Eledon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eledon Pharmaceuticals is operating at the current time. Most of Eledon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eledon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eledon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eledon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Eledon Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eledon Pharmaceuticals. If investors know Eledon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eledon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.64) | Return On Assets (0.30) | Return On Equity (0.48) |
The market value of Eledon Pharmaceuticals is measured differently than its book value, which is the value of Eledon that is recorded on the company's balance sheet. Investors also form their own opinion of Eledon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eledon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eledon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eledon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eledon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eledon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eledon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.